Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trial.
Böhm M, Butler J, Krawczyk M, Mahfoud F, Haring B, Filippatos G, Ferreira JP, Pocock SJ, Brueckmann M, Ofstad AP, Schüler E, Wanner C, Verma S, Packer M, Anker SD; EMPEROR-Preserved Trial Committees and Investigators. Böhm M, et al. Among authors: butler j. Eur J Heart Fail. 2023 Aug;25(8):1375-1383. doi: 10.1002/ejhf.2922. Epub 2023 Jun 27. Eur J Heart Fail. 2023. PMID: 37278451 Free article. Clinical Trial.
Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure.
Gheorghiade M, Vaduganathan M, Ambrosy A, Böhm M, Campia U, Cleland JG, Fedele F, Fonarow GC, Maggioni AP, Mebazaa A, Mehra M, Metra M, Nodari S, Pang PS, Ponikowski P, Sabbah HN, Komajda M, Butler J. Gheorghiade M, et al. Among authors: butler j. Heart Fail Rev. 2013 Mar;18(2):107-22. doi: 10.1007/s10741-012-9315-1. Heart Fail Rev. 2013. PMID: 22581217 Review.
Soluble guanylate cyclase: a potential therapeutic target for heart failure.
Gheorghiade M, Marti CN, Sabbah HN, Roessig L, Greene SJ, Böhm M, Burnett JC, Campia U, Cleland JG, Collins SP, Fonarow GC, Levy PD, Metra M, Pitt B, Ponikowski P, Sato N, Voors AA, Stasch JP, Butler J; Academic Research Team in Heart Failure (ART-HF). Gheorghiade M, et al. Among authors: butler j. Heart Fail Rev. 2013 Mar;18(2):123-34. doi: 10.1007/s10741-012-9323-1. Heart Fail Rev. 2013. PMID: 22622468 Review.
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study.
Felker GM, Hasselblad V, Tang WH, Hernandez AF, Armstrong PW, Fonarow GC, Voors AA, Metra M, McMurray JJ, Butler J, Heizer GM, Dickstein K, Massie BM, Atar D, Troughton RW, Anker SD, Califf RM, Starling RC, O'Connor CM. Felker GM, et al. Among authors: butler j. Eur J Heart Fail. 2012 Nov;14(11):1257-64. doi: 10.1093/eurjhf/hfs110. Epub 2012 Jul 4. Eur J Heart Fail. 2012. PMID: 22764184 Free article. Clinical Trial.
Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions.
Gheorghiade M, Vaduganathan M, Greene SJ, Mentz RJ, Adams KF Jr, Anker SD, Arnold M, Baschiera F, Cleland JG, Cotter G, Fonarow GC, Giordano C, Metra M, Misselwitz F, Mühlhofer E, Nodari S, Frank Peacock W, Pieske BM, Sabbah HN, Sato N, Shah MR, Stockbridge NL, Teerlink JR, van Veldhuisen DJ, Zalewski A, Zannad F, Butler J. Gheorghiade M, et al. Among authors: butler j. Heart Fail Rev. 2014 Mar;19(2):135-52. doi: 10.1007/s10741-012-9361-8. Heart Fail Rev. 2014. PMID: 23099992 Free PMC article.
Treatment of anemia with darbepoetin alfa in systolic heart failure.
Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ; RED-HF Committees; RED-HF Investigators. Swedberg K, et al. N Engl J Med. 2013 Mar 28;368(13):1210-9. doi: 10.1056/NEJMoa1214865. Epub 2013 Mar 10. N Engl J Med. 2013. PMID: 23473338 Free article. Clinical Trial.
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
Gheorghiade M, Fonarow GC, van Veldhuisen DJ, Cleland JG, Butler J, Epstein AE, Patel K, Aban IB, Aronow WS, Anker SD, Ahmed A. Gheorghiade M, et al. Among authors: butler j. Eur Heart J. 2013 May;34(20):1489-97. doi: 10.1093/eurheartj/eht120. Epub 2013 Apr 16. Eur Heart J. 2013. PMID: 23592708 Free PMC article. Clinical Trial.
Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
Greene SJ, Gheorghiade M, Vaduganathan M, Ambrosy AP, Mentz RJ, Subacius H, Maggioni AP, Nodari S, Konstam MA, Butler J, Filippatos G; EVEREST Trial investigators. Greene SJ, et al. Among authors: butler j. Eur J Heart Fail. 2013 Dec;15(12):1401-11. doi: 10.1093/eurjhf/hft110. Epub 2013 Jul 11. Eur J Heart Fail. 2013. PMID: 23845795 Free PMC article. Clinical Trial.
High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial.
Kalogeropoulos AP, Tang WH, Hsu A, Felker GM, Hernandez AF, Troughton RW, Voors AA, Anker SD, Metra M, McMurray JJ, Massie BM, Ezekowitz JA, Califf RM, O'Connor CM, Starling RC, Butler J. Kalogeropoulos AP, et al. Among authors: butler j. J Card Fail. 2014 May;20(5):319-26. doi: 10.1016/j.cardfail.2014.02.002. Epub 2014 Feb 12. J Card Fail. 2014. PMID: 24530944 Clinical Trial.
The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial.
Greene SJ, Vaduganathan M, Wilcox JE, Harinstein ME, Maggioni AP, Subacius H, Zannad F, Konstam MA, Chioncel O, Yancy CW, Swedberg K, Butler J, Bonow RO, Gheorghiade M; EVEREST Trial Investigators. Greene SJ, et al. Among authors: butler j. JACC Heart Fail. 2013 Dec;1(6):488-96. doi: 10.1016/j.jchf.2013.08.005. Epub 2013 Dec 2. JACC Heart Fail. 2013. PMID: 24622000 Free article. Clinical Trial.
6,106 results